| Fuente | Nº Citas | Fecha Actualización |
|---|---|---|
| wos | 0 | 20-07-2025 |
Año: 2024
Journal Impact Factor (JIF): 5.70
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | 37/230 | Q1 | T1 | D2 |
| PERIPHERAL VASCULAR DISEASE | SCIE | 11/98 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,330
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CARDIAC & CARDIOVASCULAR SYSTEMS | 42/230 | Q1 | T1 | D2 | 81,96 |
| PERIPHERAL VASCULAR DISEASE | 13/99 | Q1 | T1 | D2 | 87,37 |
Año:
2024
CiteScore:
9,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 43/397 | Q1 | T1 | D2 |
SJR año:
2024
Factor de Impacto:
1,762
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 51/404 | Q1 | T1 | D2 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Elshorbagy, A | Imperial College London Department of Primary Care and Public Health (England) |
| 2 | Stevens, C | Imperial College London Department of Primary Care and Public Health (England) |
| 3 | Vallejo-Vaz, A | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERESP; University of Seville Faculty of Medicine; Imperial College London Department of Primary Care and Public Health (Spain) |
| 4 | Dharmayat, K | Imperial College London Department of Primary Care and Public Health (England) |
| 5 | Lyons, A | Imperial College London Department of Primary Care and Public Health (England) |
| 6 | Bourbon, M | Instituto Nacional de Saúde Dr. Ricardo Jorge; University of Lisbon Biosystems and Integrative Sciences Institute (Portugal) |
| 7 | Chora, J | Instituto Nacional de Saúde Dr. Ricardo Jorge; University of Lisbon Biosystems and Integrative Sciences Institute (Portugal) |
| 8 | Humphries, S | University College London Institute of Cardiovascular Science (England) |
| 9 | Catapano, A | IRCCS Multimedica; Epidemiol & Prevent Pharmacol Serv SEFAP (Italy) |
| 10 | Hovingh, G | University of Amsterdam (Netherlands) |
| 11 | Mata, P | Fdn Hipercolesterolemia Familiar (Spain) |
| 12 | Santos, R | Universidade de Sao Paulo (Brazil) |
| 13 | Soran, H | Manchester University NHS Foundation Trust (England) |
| 14 | Watts, G | University of Western Australia; The University of Western Australia Medical School (Australia) |
| 15 | Raal, FJ | University of the Witwatersrand Johannesburg Faculty of Health Sciences (South Africa) |
| 16 | Freiberger, T | Masaryk University Brno (Czech Republic) |
| 17 | Ray, K | Imperial College London Department of Primary Care and Public Health (England) |
